.png
)
Jan 8, 2025 In a significant regulatory move, the Indian government has imposed a nationwide ban on the manufacture, sale, and distribution of all formulations of nimesulide, a commonly used painkiller for animals. The decision, which was officially notified on…
Jan 6, 2025 In a significant development for Micro, Small, and Medium Enterprises (MSME) in the pharmaceutical sector, the Ministry of Health and Family Welfare (MoHFW) has proposed an extension for compliance with the updated Good Manufacturing Practice (GMP) standards…
January 6, 2023 Government of India vide gazette notification no. GSR 922 (E) dated 28.12.2023 has notified new set of rules and regulations for implementation of Good Manufacturing Practices for manufacturing of pharmaceutical products. The new rules are covered under…
Jan 2, 2024 Central Drugs Standard Control Organization, Government of India has announced that w.e.f 01.01.2024 online applications for some of the registration/ licensure activities shall now be made through NSWS portal i.e. www.nsws.gov.in. Accordingly, all stakeholders shall henceforth apply…
Dec 22, 2023 US Food and Drugs Administration (USFDA) has approved TARPEYO (budesonide) delayed release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. TARPEYO was first approved…